All Posts: cancer
-
Tamoxifen Resistance Linked to High Estrogen Levels in Utero
WASHINGTON — An animal study suggests that resistance to tamoxifen therapy in some estrogen receptor positive breast cancers may originate from in utero exposure to endocrine disrupting chemicals. The study provides a new path forward in human research as about half of the breast cancers treated with this common cancer therapy do not respond well, say researchers at the Georgetown Lombardi Comprehensive Cancer Center, who led the multi-institutional research.
Category: News Release
-
MEDIA ADVISORY: 2016 Ruesch Center Policy Briefing: Fighting a Smarter War on Cancer
WASHINGTON – The Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center hosts its 2016 Cancer Policy Briefing, Wednesday, September 14 from 9:00 to 11:30 a.m. at the Georgetown University Law Center.
Category: News Release
-
Switch from Observation Only to Active Treatment by Patients with Prostate Cancer Varies by Race and Ethnicity
NEW YORK, NY — Assessment of clinical and nonclinical factors indicates that black men on active surveillance are more likely to pursue active treatment, according to a new study
published in The Journal of Urology.Category: News Release
-
Study Tests New Breast Cancer Drug in African American Women
WASHINGTON — The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling patients at six institutions in Washington, DC, Maryland, Alabama and New Jersey.
Category: News Release
-
In Mice, Daughters of Overweight Dads Have Altered Breast Tissue, Higher Cancer Risk
WASHINGTON — Obese male mice and normal weight female mice produce female pups that are overweight at birth through childhood, and have delayed development of their breast tissue as well as increased rates of breast cancer.
Category: News Release
-
Gostin Appointed to National Cancer Advisory Board
President Obama has tapped Lawrence O. Gostin, Georgetown University Professor and faculty director of the O’Neill Institute for National and Global Health Law at Georgetown Law to serve as a member of the National Cancer Advisory Board (NCAB). Gostin is also a professor of medicine at Georgetown’s School of Medicine.
Category: GUMC Stories
-
Georgetown Data Scientist Comments on Biden's Announcement on Open Genomics Database
CHICAGO — Vice President Joe Biden will reportedly announce the launch of a cancer database with genomic data and other patient information called “Genomic Data Commons” that will be open to researchers. Biden will discuss the effort when he addresses attendees at the 2016 American Society for Clinical Oncology Annual Meeting in Chicago about the National Cancer Moonshot Initiative.
Category: News Release
-
GI Cancers Alliance Launches to Elevate Patients’ Voices Against Gastrointestinal Cancers
CHICAGO — Twenty cancer advocacy groups from around the United States announce the formation of the GI Cancers Alliance, committed to the fight against gastrointestinal cancers, which include many of the leading cancer killers. The groups’ leadership met June 4 during the ASCO Annual Meeting in Chicago to elect its chairs.
Category: News Release
-
Georgetown Professor: FDA Deeming Rule has “Good and Bad Aspects”
WASHINGTON — In a historic development to the long-awaited “deeming rule,” the FDA today has finalized its authority to regulate all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco.
Category: News Release
-
Top Cancer Leaders, Including Atkins, Brief Congress
April 25, 2016 — Georgetown Lombardi Comprehensive Cancer Center’s Michael Atkins, MD, translated his vast knowledge of cancer immunology into a classroom-style lecture Monday as part of Congressional briefing.
Category: GUMC Stories